Authors:
Jego, G
Avet-Loiseau, H
Robillard, N
Moreau, P
Amiot, M
Harousseau, JL
Pellat-Deceunynck, C
Bataille, R
Citation: G. Jego et al., Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF, LEUK RES, 24(7), 2000, pp. 627-630
Authors:
Pellat-Deceunynck, C
Mellerin, MP
Labarriere, N
Jego, G
Moreau-Aubry, A
Harousseau, JL
Jotereau, F
Bataille, R
Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809
Authors:
Pellat-Deceunynck, C
Jego, G
Harousseau, JL
Vie, H
Bataille, R
Citation: C. Pellat-deceunynck et al., Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells, CLIN CANC R, 5(3), 1999, pp. 705-709
Authors:
Jego, G
Robillard, N
Puthier, D
Amiot, M
Accard, F
Pineau, D
Harousseau, JL
Bataille, R
Pellat-Deceunynck, C
Citation: G. Jego et al., Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells, BLOOD, 94(2), 1999, pp. 701-712
Authors:
Pellat-Deceunynck, C
Barille, S
Jego, G
Puthier, D
Robillard, N
Pineau, D
Rapp, MJ
Harousseau, JL
Amiot, M
Bataille, R
Citation: C. Pellat-deceunynck et al., The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma, LEUKEMIA, 12(12), 1998, pp. 1977-1982